Clostridium Difficile Diagnostics and Treatment Market skyrocketing at CAGR +8% by 2028 with ...

Retrieved on: 2021-02-04 12:11:15

Tags for this article:

Clostridiaceae

Gram-positive bacteria

Clostridioides difficile infection

C. Diff

Clostridioides difficile

Fidaxomicin

Click the tags to see associated articles and topics

Clostridium Difficile Diagnostics and Treatment Market skyrocketing at CAGR +8% by 2028 with .... View article details on hiswai:

Excerpt

Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Pfizer, Inc., Actelion Pharmaceuticals, Alere, Inc., Trinity Biotech, Summit Therapeutics, Baxter ...

Article found on: ksusentinel.com

View Original Article